Advertisement
Product › Details
calreticulin (CALR) biomarker
Next higher product group | genomic marker / genetic marker (diagnostics) | |
Status | 2014-04-10 development existent | |
Organisation | Qiagen (Group) | |
Original research | Ce-M-M-Research Center for Molecular Medicine of the Austrian Academy of Sciences (CeMM) | |
Record changed: 2023-07-10 |
Advertisement
More documents for diagnostic marker
- [1] Catalym GmbH. (5/4/21). "Press Release: Catalym Appoints Industry Leader Dr. Phil L’Huillier as Chief Executive Officer". Munich....
- [2] SphingoTec GmbH. (12/16/19). "Press Release: SphingoTec’s Proprietary Biomarker bio-ADM Detects Residual Congestion in Patients with Heart Failure". Hennigsdorf....
- [3] Centogene AG. (5/29/18). "Press Release: Centogene Announces Agreement with Aldeyra Therapeutics for the Advancement of Novel Therapeutics for Patients with Sjögren-Larsson Syndrome". Rostock....
- [4] Qiagen N.V.. (6/3/17). "Press Release: Qiagen Expands Biomarker Content Portfolio to Support Greater Use of Molecular Diagnostics for Immuno-oncology Therapies". Hilden & Germantown, MD....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top